Belize
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.55 (0.46 - 0.65) | 2019 | Modelled | IHME |
| 0.54 (0.45 - 0.63) | 2018 | Modelled | IHME |
| 0.54 (0.44 - 0.63) | 2017 | Modelled | IHME |
| 0.54 (0.44 - 0.63) | 2016 | Modelled | IHME |
| 0.54 (0.44 - 0.64) | 2015 | Modelled | IHME |
| 0.55 (0.45 - 0.65) | 2014 | Modelled | IHME |
| 0.56 (0.46 - 0.66) | 2013 | Modelled | IHME |
| 0.57 (0.47 - 0.68) | 2012 | Modelled | IHME |
| 0.59 (0.48 - 0.70) | 2011 | Modelled | IHME |
| 0.61 (0.49 - 0.72) | 2010 | Modelled | IHME |
| 0.62 (0.50 - 0.74) | 2009 | Modelled | IHME |
| 0.64 (0.52 - 0.75) | 2008 | Modelled | IHME |
| 0.65 (0.53 - 0.77) | 2007 | Modelled | IHME |
| 0.67 (0.55 - 0.79) | 2006 | Modelled | IHME |
| 0.69 (0.56 - 0.81) | 2005 | Modelled | IHME |
| 0.7 (0.57 - 0.82) | 2004 | Modelled | IHME |
| 0.71 (0.58 - 0.83) | 2003 | Modelled | IHME |
| 0.72 (0.58 - 0.85) | 2002 | Modelled | IHME |
| 0.73 (0.60 - 0.86) | 2001 | Modelled | IHME |
| 0.74 (0.61 - 0.89) | 2000 | Modelled | IHME |
| 0.76 (0.61 - 0.91) | 1999 | Modelled | IHME |
| 0.78 (0.64 - 0.94) | 1998 | Modelled | IHME |
| 0.8 (0.65 - 0.96) | 1997 | Modelled | IHME |
| 0.82 (0.66 - 0.99) | 1996 | Modelled | IHME |
| 0.83 (0.67 - 1) | 1995 | Modelled | IHME |
| 0.83 (0.67 - 1) | 1994 | Modelled | IHME |
| 0.83 (0.68 - 0.99) | 1993 | Modelled | IHME |
| 0.84 (0.69 - 0.99) | 1992 | Modelled | IHME |
| 0.84 (0.69 - 0.99) | 1991 | Modelled | IHME |
| 0.84 (0.69 - 0.99) | 1990 | Modelled | IHME |
| 4.01 (3.04 - 5.25) | 2015 | Modelled | WHO |
| 1.4 (0.60 - 1.70) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 4.71 (3.90 - 5.67) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.07 (0.05 - 0.09) | 2019 | Modelled | IHME |
| 0.07 (0.05 - 0.09) | 2018 | Modelled | IHME |
| 0.07 (0.05 - 0.10) | 2017 | Modelled | IHME |
| 0.07 (0.05 - 0.10) | 2016 | Modelled | IHME |
| 0.08 (0.06 - 0.10) | 2015 | Modelled | IHME |
| 0.08 (0.06 - 0.11) | 2014 | Modelled | IHME |
| 0.09 (0.06 - 0.12) | 2013 | Modelled | IHME |
| 0.09 (0.06 - 0.12) | 2012 | Modelled | IHME |
| 0.09 (0.06 - 0.13) | 2011 | Modelled | IHME |
| 0.1 (0.07 - 0.14) | 2010 | Modelled | IHME |
| 0.1 (0.07 - 0.14) | 2009 | Modelled | IHME |
| 0.11 (0.07 - 0.14) | 2008 | Modelled | IHME |
| 0.11 (0.07 - 0.15) | 2007 | Modelled | IHME |
| 0.11 (0.08 - 0.15) | 2006 | Modelled | IHME |
| 0.12 (0.08 - 0.15) | 2005 | Modelled | IHME |
| 0.12 (0.08 - 0.16) | 2004 | Modelled | IHME |
| 0.13 (0.09 - 0.16) | 2003 | Modelled | IHME |
| 0.13 (0.09 - 0.17) | 2002 | Modelled | IHME |
| 0.14 (0.10 - 0.18) | 2001 | Modelled | IHME |
| 0.15 (0.10 - 0.20) | 2000 | Modelled | IHME |
| 0.19 (0.13 - 0.25) | 1999 | Modelled | IHME |
| 0.28 (0.20 - 0.37) | 1998 | Modelled | IHME |
| 0.38 (0.27 - 0.51) | 1997 | Modelled | IHME |
| 0.46 (0.33 - 0.62) | 1996 | Modelled | IHME |
| 0.5 (0.35 - 0.67) | 1995 | Modelled | IHME |
| 0.5 (0.36 - 0.67) | 1994 | Modelled | IHME |
| 0.51 (0.36 - 0.67) | 1993 | Modelled | IHME |
| 0.51 (0.36 - 0.67) | 1992 | Modelled | IHME |
| 0.51 (0.36 - 0.67) | 1991 | Modelled | IHME |
| 0.51 (0.36 - 0.68) | 1990 | Modelled | IHME |
| 1.49 (0.98 - 2.21) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,557 (1,275 - 1,845) | 1990 | Modelled | IHME |
| 1,595 (1,306 - 1,894) | 1991 | Modelled | IHME |
| 1,632 (1,341 - 1,940) | 1992 | Modelled | IHME |
| 1,669 (1,363 - 1,985) | 1993 | Modelled | IHME |
| 1,706 (1,382 - 2,045) | 1994 | Modelled | IHME |
| 1,743 (1,405 - 2,105) | 1995 | Modelled | IHME |
| 1,769 (1,428 - 2,127) | 1996 | Modelled | IHME |
| 1,776 (1,441 - 2,124) | 1997 | Modelled | IHME |
| 1,774 (1,440 - 2,124) | 1998 | Modelled | IHME |
| 1,772 (1,432 - 2,110) | 1999 | Modelled | IHME |
| 1,781 (1,452 - 2,129) | 2000 | Modelled | IHME |
| 1,804 (1,472 - 2,133) | 2001 | Modelled | IHME |
| 1,833 (1,488 - 2,159) | 2002 | Modelled | IHME |
| 1,865 (1,521 - 2,192) | 2003 | Modelled | IHME |
| 1,898 (1,551 - 2,240) | 2004 | Modelled | IHME |
| 1,927 (1,573 - 2,277) | 2005 | Modelled | IHME |
| 1,948 (1,589 - 2,293) | 2006 | Modelled | IHME |
| 1,963 (1,597 - 2,310) | 2007 | Modelled | IHME |
| 1,972 (1,600 - 2,328) | 2008 | Modelled | IHME |
| 1,980 (1,597 - 2,350) | 2009 | Modelled | IHME |
| 1,990 (1,598 - 2,381) | 2010 | Modelled | IHME |
| 1,997 (1,616 - 2,366) | 2011 | Modelled | IHME |
| 1,998 (1,630 - 2,353) | 2012 | Modelled | IHME |
| 2,000 (1,639 - 2,358) | 2013 | Modelled | IHME |
| 2,011 (1,647 - 2,375) | 2014 | Modelled | IHME |
| 2,036 (1,663 - 2,407) | 2015 | Modelled | IHME |
| 2,073 (1,708 - 2,422) | 2016 | Modelled | IHME |
| 2,115 (1,724 - 2,483) | 2017 | Modelled | IHME |
| 2,181 (1,802 - 2,524) | 2018 | Modelled | IHME |
| 2,273 (1,887 - 2,652) | 2019 | Modelled | IHME |
| 5,000 (2,000 - 6,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 1.83 (1.38 - 2.39) | 2019 | Modelled | IHME |
| 1.79 (1.37 - 2.34) | 2018 | Modelled | IHME |
| 1.75 (1.34 - 2.28) | 2017 | Modelled | IHME |
| 1.74 (1.34 - 2.24) | 2016 | Modelled | IHME |
| 1.67 (1.28 - 2.14) | 2015 | Modelled | IHME |
| 1.61 (1.23 - 2.06) | 2014 | Modelled | IHME |
| 1.55 (1.20 - 1.96) | 2013 | Modelled | IHME |
| 1.51 (1.18 - 1.92) | 2012 | Modelled | IHME |
| 1.52 (1.19 - 1.91) | 2011 | Modelled | IHME |
| 1.5 (1.17 - 1.88) | 2010 | Modelled | IHME |
| 1.55 (1.21 - 1.95) | 2009 | Modelled | IHME |
| 1.68 (1.31 - 2.10) | 2008 | Modelled | IHME |
| 1.86 (1.45 - 2.34) | 2007 | Modelled | IHME |
| 2.01 (1.56 - 2.53) | 2006 | Modelled | IHME |
| 2.07 (1.60 - 2.60) | 2005 | Modelled | IHME |
| 2.11 (1.62 - 2.65) | 2004 | Modelled | IHME |
| 2.12 (1.64 - 2.68) | 2003 | Modelled | IHME |
| 2.18 (1.69 - 2.75) | 2002 | Modelled | IHME |
| 2.28 (1.77 - 2.90) | 2001 | Modelled | IHME |
| 2.35 (1.83 - 2.99) | 2000 | Modelled | IHME |
| 2.4 (1.89 - 3.04) | 1999 | Modelled | IHME |
| 2.36 (1.89 - 2.95) | 1998 | Modelled | IHME |
| 2.33 (1.87 - 2.87) | 1997 | Modelled | IHME |
| 2.32 (1.88 - 2.85) | 1996 | Modelled | IHME |
| 2.27 (1.85 - 2.76) | 1995 | Modelled | IHME |
| 2.19 (1.78 - 2.68) | 1994 | Modelled | IHME |
| 2.2 (1.78 - 2.66) | 1993 | Modelled | IHME |
| 2.18 (1.77 - 2.63) | 1992 | Modelled | IHME |
| 2.19 (1.78 - 2.65) | 1991 | Modelled | IHME |
| 2.19 (1.75 - 2.66) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 7 (6 - 10) | 2019 | Modelled | IHME |
| 7 (5 - 9) | 2018 | Modelled | IHME |
| 7 (5 - 9) | 2017 | Modelled | IHME |
| 7 (5 - 9) | 2016 | Modelled | IHME |
| 6 (5 - 8) | 2015 | Modelled | IHME |
| 6 (5 - 8) | 2014 | Modelled | IHME |
| 6 (4 - 7) | 2013 | Modelled | IHME |
| 5 (4 - 7) | 2012 | Modelled | IHME |
| 5 (4 - 6) | 2011 | Modelled | IHME |
| 5 (4 - 6) | 2010 | Modelled | IHME |
| 5 (4 - 6) | 2009 | Modelled | IHME |
| 5 (4 - 6) | 2008 | Modelled | IHME |
| 6 (4 - 7) | 2007 | Modelled | IHME |
| 6 (5 - 7) | 2006 | Modelled | IHME |
| 6 (4 - 7) | 2005 | Modelled | IHME |
| 6 (4 - 7) | 2004 | Modelled | IHME |
| 6 (4 - 7) | 2003 | Modelled | IHME |
| 6 (4 - 7) | 2002 | Modelled | IHME |
| 6 (4 - 7) | 2001 | Modelled | IHME |
| 6 (4 - 7) | 2000 | Modelled | IHME |
| 6 (4 - 7) | 1999 | Modelled | IHME |
| 5 (4 - 7) | 1998 | Modelled | IHME |
| 5 (4 - 6) | 1997 | Modelled | IHME |
| 5 (4 - 6) | 1996 | Modelled | IHME |
| 5 (4 - 6) | 1995 | Modelled | IHME |
| 4 (4 - 5) | 1994 | Modelled | IHME |
| 4 (4 - 5) | 1993 | Modelled | IHME |
| 4 (3 - 5) | 1992 | Modelled | IHME |
| 4 (3 - 5) | 1991 | Modelled | IHME |
| 4 (3 - 5) | 1990 | Modelled | IHME |
| 25 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 28 (21 - 37) | 2019 | Modelled | IHME |
| 28 (22 - 37) | 2018 | Modelled | IHME |
| 28 (22 - 37) | 2017 | Modelled | IHME |
| 28 (22 - 37) | 2016 | Modelled | IHME |
| 28 (21 - 36) | 2015 | Modelled | IHME |
| 28 (21 - 36) | 2014 | Modelled | IHME |
| 28 (21 - 36) | 2013 | Modelled | IHME |
| 28 (21 - 36) | 2012 | Modelled | IHME |
| 28 (22 - 36) | 2011 | Modelled | IHME |
| 28 (21 - 36) | 2010 | Modelled | IHME |
| 28 (22 - 36) | 2009 | Modelled | IHME |
| 28 (22 - 36) | 2008 | Modelled | IHME |
| 29 (22 - 37) | 2007 | Modelled | IHME |
| 29 (22 - 37) | 2006 | Modelled | IHME |
| 29 (23 - 37) | 2005 | Modelled | IHME |
| 29 (23 - 38) | 2004 | Modelled | IHME |
| 30 (23 - 38) | 2003 | Modelled | IHME |
| 30 (23 - 38) | 2002 | Modelled | IHME |
| 30 (23 - 38) | 2001 | Modelled | IHME |
| 29 (23 - 38) | 2000 | Modelled | IHME |
| 29 (22 - 38) | 1999 | Modelled | IHME |
| 29 (22 - 37) | 1998 | Modelled | IHME |
| 29 (22 - 37) | 1997 | Modelled | IHME |
| 29 (22 - 37) | 1996 | Modelled | IHME |
| 29 (22 - 37) | 1995 | Modelled | IHME |
| 28 (22 - 37) | 1994 | Modelled | IHME |
| 28 (22 - 37) | 1993 | Modelled | IHME |
| 28 (22 - 36) | 1992 | Modelled | IHME |
| 28 (21 - 36) | 1991 | Modelled | IHME |
| 27 (21 - 35) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of HepB birth dose
Newborns
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 70 | 2019 | Survey/reported | WHO/UNICEF |
| 55 | 2018 | Survey/reported | WHO/UNICEF |
| 67 | 2020 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 98 | 2019 | Survey/reported | WHO/UNICEF |
| 79 | 2020 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.85 (1.47 - 2.30) | 2019 | Modelled | IHME |
| 1.84 (1.47 - 2.30) | 2018 | Modelled | IHME |
| 1.82 (1.46 - 2.29) | 2017 | Modelled | IHME |
| 1.8 (1.44 - 2.26) | 2016 | Modelled | IHME |
| 1.78 (1.42 - 2.22) | 2015 | Modelled | IHME |
| 1.76 (1.40 - 2.20) | 2014 | Modelled | IHME |
| 1.75 (1.40 - 2.18) | 2013 | Modelled | IHME |
| 1.74 (1.39 - 2.18) | 2012 | Modelled | IHME |
| 1.73 (1.39 - 2.16) | 2011 | Modelled | IHME |
| 1.72 (1.39 - 2.16) | 2010 | Modelled | IHME |
| 1.73 (1.39 - 2.16) | 2009 | Modelled | IHME |
| 1.74 (1.40 - 2.18) | 2008 | Modelled | IHME |
| 1.75 (1.40 - 2.19) | 2007 | Modelled | IHME |
| 1.77 (1.41 - 2.20) | 2006 | Modelled | IHME |
| 1.77 (1.42 - 2.21) | 2005 | Modelled | IHME |
| 1.77 (1.42 - 2.23) | 2004 | Modelled | IHME |
| 1.78 (1.43 - 2.23) | 2003 | Modelled | IHME |
| 1.78 (1.43 - 2.22) | 2002 | Modelled | IHME |
| 1.78 (1.43 - 2.22) | 2001 | Modelled | IHME |
| 1.78 (1.43 - 2.23) | 2000 | Modelled | IHME |
| 1.77 (1.42 - 2.22) | 1999 | Modelled | IHME |
| 1.76 (1.42 - 2.20) | 1998 | Modelled | IHME |
| 1.75 (1.40 - 2.18) | 1997 | Modelled | IHME |
| 1.73 (1.39 - 2.15) | 1996 | Modelled | IHME |
| 1.73 (1.37 - 2.16) | 1995 | Modelled | IHME |
| 1.73 (1.38 - 2.15) | 1994 | Modelled | IHME |
| 1.73 (1.39 - 2.17) | 1993 | Modelled | IHME |
| 1.73 (1.39 - 2.17) | 1992 | Modelled | IHME |
| 1.74 (1.39 - 2.18) | 1991 | Modelled | IHME |
| 1.75 (1.39 - 2.20) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.51 (0.38 - 0.76) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 3,245 (2,585 - 4,082) | 1990 | Modelled | IHME |
| 3,308 (2,642 - 4,147) | 1991 | Modelled | IHME |
| 3,378 (2,712 - 4,237) | 1992 | Modelled | IHME |
| 3,455 (2,774 - 4,331) | 1993 | Modelled | IHME |
| 3,538 (2,825 - 4,409) | 1994 | Modelled | IHME |
| 3,626 (2,887 - 4,534) | 1995 | Modelled | IHME |
| 3,730 (2,985 - 4,633) | 1996 | Modelled | IHME |
| 3,855 (3,099 - 4,806) | 1997 | Modelled | IHME |
| 3,992 (3,219 - 4,999) | 1998 | Modelled | IHME |
| 4,133 (3,317 - 5,173) | 1999 | Modelled | IHME |
| 4,265 (3,429 - 5,332) | 2000 | Modelled | IHME |
| 4,393 (3,522 - 5,485) | 2001 | Modelled | IHME |
| 4,529 (3,636 - 5,660) | 2002 | Modelled | IHME |
| 4,673 (3,753 - 5,858) | 2003 | Modelled | IHME |
| 4,822 (3,856 - 6,052) | 2004 | Modelled | IHME |
| 4,976 (3,980 - 6,218) | 2005 | Modelled | IHME |
| 5,121 (4,096 - 6,384) | 2006 | Modelled | IHME |
| 5,253 (4,208 - 6,570) | 2007 | Modelled | IHME |
| 5,380 (4,321 - 6,729) | 2008 | Modelled | IHME |
| 5,513 (4,440 - 6,900) | 2009 | Modelled | IHME |
| 5,664 (4,556 - 7,093) | 2010 | Modelled | IHME |
| 5,840 (4,704 - 7,311) | 2011 | Modelled | IHME |
| 6,033 (4,820 - 7,582) | 2012 | Modelled | IHME |
| 6,240 (4,990 - 7,783) | 2013 | Modelled | IHME |
| 6,455 (5,139 - 8,042) | 2014 | Modelled | IHME |
| 6,672 (5,342 - 8,346) | 2015 | Modelled | IHME |
| 6,915 (5,536 - 8,662) | 2016 | Modelled | IHME |
| 7,159 (5,746 - 9,001) | 2017 | Modelled | IHME |
| 7,371 (5,886 - 9,245) | 2018 | Modelled | IHME |
| 7,569 (6,046 - 9,440) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 560 (420 - 830) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.62 (2.68 - 4.78) | 2019 | Modelled | IHME |
| 3.55 (2.68 - 4.64) | 2018 | Modelled | IHME |
| 3.46 (2.62 - 4.49) | 2017 | Modelled | IHME |
| 3.44 (2.62 - 4.46) | 2016 | Modelled | IHME |
| 3.31 (2.53 - 4.34) | 2015 | Modelled | IHME |
| 3.17 (2.44 - 4.12) | 2014 | Modelled | IHME |
| 3.02 (2.34 - 3.92) | 2013 | Modelled | IHME |
| 2.93 (2.28 - 3.76) | 2012 | Modelled | IHME |
| 2.92 (2.26 - 3.72) | 2011 | Modelled | IHME |
| 2.87 (2.22 - 3.66) | 2010 | Modelled | IHME |
| 2.81 (2.17 - 3.61) | 2009 | Modelled | IHME |
| 2.77 (2.15 - 3.56) | 2008 | Modelled | IHME |
| 2.79 (2.16 - 3.57) | 2007 | Modelled | IHME |
| 2.79 (2.17 - 3.58) | 2006 | Modelled | IHME |
| 2.77 (2.16 - 3.54) | 2005 | Modelled | IHME |
| 2.81 (2.18 - 3.60) | 2004 | Modelled | IHME |
| 2.84 (2.19 - 3.63) | 2003 | Modelled | IHME |
| 2.92 (2.26 - 3.72) | 2002 | Modelled | IHME |
| 3.07 (2.37 - 3.92) | 2001 | Modelled | IHME |
| 3.17 (2.45 - 4.02) | 2000 | Modelled | IHME |
| 3.21 (2.49 - 4.09) | 1999 | Modelled | IHME |
| 3.11 (2.43 - 3.93) | 1998 | Modelled | IHME |
| 3.03 (2.39 - 3.79) | 1997 | Modelled | IHME |
| 2.94 (2.33 - 3.63) | 1996 | Modelled | IHME |
| 2.81 (2.24 - 3.48) | 1995 | Modelled | IHME |
| 2.71 (2.14 - 3.38) | 1994 | Modelled | IHME |
| 2.69 (2.13 - 3.35) | 1993 | Modelled | IHME |
| 2.67 (2.13 - 3.35) | 1992 | Modelled | IHME |
| 2.7 (2.15 - 3.36) | 1991 | Modelled | IHME |
| 2.76 (2.20 - 3.48) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 15 (11 - 20) | 2019 | Modelled | IHME |
| 14 (11 - 19) | 2018 | Modelled | IHME |
| 14 (10 - 18) | 2017 | Modelled | IHME |
| 13 (10 - 17) | 2016 | Modelled | IHME |
| 12 (10 - 16) | 2015 | Modelled | IHME |
| 12 (9 - 15) | 2014 | Modelled | IHME |
| 11 (8 - 14) | 2013 | Modelled | IHME |
| 10 (8 - 13) | 2012 | Modelled | IHME |
| 10 (8 - 13) | 2011 | Modelled | IHME |
| 9 (7 - 12) | 2010 | Modelled | IHME |
| 9 (7 - 12) | 2009 | Modelled | IHME |
| 9 (7 - 11) | 2008 | Modelled | IHME |
| 8 (6 - 11) | 2007 | Modelled | IHME |
| 8 (6 - 10) | 2006 | Modelled | IHME |
| 8 (6 - 10) | 2005 | Modelled | IHME |
| 8 (6 - 10) | 2004 | Modelled | IHME |
| 7 (6 - 10) | 2003 | Modelled | IHME |
| 7 (6 - 9) | 2002 | Modelled | IHME |
| 8 (6 - 10) | 2001 | Modelled | IHME |
| 8 (6 - 10) | 2000 | Modelled | IHME |
| 7 (6 - 10) | 1999 | Modelled | IHME |
| 7 (6 - 9) | 1998 | Modelled | IHME |
| 7 (5 - 8) | 1997 | Modelled | IHME |
| 6 (5 - 8) | 1996 | Modelled | IHME |
| 6 (5 - 7) | 1995 | Modelled | IHME |
| 6 (4 - 7) | 1994 | Modelled | IHME |
| 5 (4 - 7) | 1993 | Modelled | IHME |
| 5 (4 - 7) | 1992 | Modelled | IHME |
| 5 (4 - 6) | 1991 | Modelled | IHME |
| 5 (4 - 6) | 1990 | Modelled | IHME |
| 13 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 21 (15 - 28) | 2019 | Modelled | IHME |
| 21 (15 - 28) | 2018 | Modelled | IHME |
| 21 (15 - 28) | 2017 | Modelled | IHME |
| 21 (15 - 28) | 2016 | Modelled | IHME |
| 21 (15 - 28) | 2015 | Modelled | IHME |
| 21 (15 - 28) | 2014 | Modelled | IHME |
| 21 (15 - 28) | 2013 | Modelled | IHME |
| 22 (15 - 28) | 2012 | Modelled | IHME |
| 22 (15 - 28) | 2011 | Modelled | IHME |
| 22 (15 - 29) | 2010 | Modelled | IHME |
| 22 (15 - 29) | 2009 | Modelled | IHME |
| 22 (15 - 28) | 2008 | Modelled | IHME |
| 22 (15 - 28) | 2007 | Modelled | IHME |
| 22 (15 - 28) | 2006 | Modelled | IHME |
| 22 (15 - 28) | 2005 | Modelled | IHME |
| 22 (15 - 28) | 2004 | Modelled | IHME |
| 22 (15 - 29) | 2003 | Modelled | IHME |
| 22 (15 - 29) | 2002 | Modelled | IHME |
| 22 (15 - 29) | 2001 | Modelled | IHME |
| 22 (16 - 29) | 2000 | Modelled | IHME |
| 22 (16 - 29) | 1999 | Modelled | IHME |
| 23 (16 - 30) | 1998 | Modelled | IHME |
| 23 (16 - 30) | 1997 | Modelled | IHME |
| 24 (17 - 31) | 1996 | Modelled | IHME |
| 24 (17 - 31) | 1995 | Modelled | IHME |
| 24 (17 - 31) | 1994 | Modelled | IHME |
| 24 (17 - 31) | 1993 | Modelled | IHME |
| 24 (17 - 32) | 1992 | Modelled | IHME |
| 25 (18 - 32) | 1991 | Modelled | IHME |
| 25 (18 - 33) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.07
(%)
2019, latest modelled
(0.05 - 0.09(%))
IHME
Prevalence PWID
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines